side effects.of semaglutide Semaglutide: Double-edged Sword with Risks and Benefits Harvard and CDC study: Serious

June 2, 2026 Results of an American College of Radiology-managed retrospective study involving 110,000 womenpresented at the 2026 ASCO Annual Meeting, shows that those who took GLP-1 medications were up to 35% less likely to develop breast cancer than those who did not take GLP-1 drugs. ACR urges funding of a large prospective study to clarify impact of these drugs on cancer incidence and prevention.

But it also creates a new challenge: people often struggle to eat enough protein

Learn real risks, side effects, and how it compares to Wegovy, plus tips to protect your sleep and improve rest.

Proudly registered with the FDA as a 503B, we serve pharmacies, doctors' offices, clinics, and hospitals

Wash your hands, remove the pen cap, and check the solution is clear before use